EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

“The COVID-19 pandemic in BRICS: Milestones, interventions, and molecular epidemiology”

Stephanie van Wyk, Monika Moir iD, Anindita Banerjee, Georgii A Bazykin, Nidhan K Biswas, Nikita Sitharam, Saumitra Das, Wentai Ma, Arindam Maitra, Anup Mazumder iD, Wasim Abdool Karim, Alessandra Pavan Lamarca iD und 8 weitere

PLOS Global Public Health · 20.12.2024 · 4 (12) · e0003023

DOI: 10.1371/journal.pgph.0003023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Global Public Health, online erschienen am 20.12.2024. Verfasst von Stephanie van Wyk und 19 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South A…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, FIC NIH HHS, Department of Science and Innovation, South Africa.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brazil, Russia, India, China, and South Africa (BRICS) are a group of developing countries with shared economic, healthcare, and scientific interests. These countries navigate multiple syndemics, and the COVID-19 pandemic placed severe strain on already burdened BRICS’ healthcare systems, hampering effective pandemic interventions. Genomic surveillance and molecular epidemiology remain indispensable tools for facilitating informed pandemic intervention. To evaluate the combined manner in which the pandemic unfolded in BRICS countries, we reviewed the BRICS pandemic epidemiological and genomic milestones, which included the first reported cases and deaths, and pharmaceutical and non-pharmaceutical interventions implemented in these countries. To assess the development of genomic surveillance capacity and efficiency over the pandemic, we analyzed the turnaround time from sample collection to data availability and the technologies used for genomic analysis. This data provided information on the laboratory capacities that enable the detection of emerging SARS-CoV-2 variants and highlight their potential for monitoring other pathogens in ongoing public health efforts. Our analyses indicated that BRICS suffered >105.6M COVID-19 infections, resulting in >1.7M deaths. BRICS countries detected intricate genetic combinations of SARS-CoV-2 variants that fueled country-specific pandemic waves. BRICS’ genomic surveillance programs enabled the identification and characterization of the majority of globally circulating Variants of Concern (VOCs) and their descending lineages. Pandemic intervention strategies first implemented by BRICS countries included non-pharmaceutical interventions during the onset of the pandemic, such as nationwide lockdowns, quarantine procedures, the establishment of fever clinics, and mask mandates- which were emulated internationally. Vaccination rollout strategies complemented this, some representing the first of their kind. Improvements in BRICS sequencing and data generation turnaround time facilitated quicker detection of circulating and emerging variants, supported by investments in sequencing and bioinformatic infrastructure. Intra-BRICS cooperation contributed to the ongoing intervention in COVID-19 and other pandemics, enhancing collective capabilities in addressing these health challenges. The data generated continues to inform BRICS-centric pandemic intervention strategies and influences global health matters. The increased laboratory and bioinformatic capacity post-COVID-19 will support the detection of emerging pathogens.

Autor:innen und Institutionen

  • Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.
  • BRICS-National Institute of Biomedical Genomics, Kalyani, West Bengal, India.
  • A.A. Kharkevich Institute for Information Transmission Problems of the Russian Academy of Sciences, Moscow, Russia.
  • Indian Institute of Science, Bengaluru, Karnataka, India.
  • Beijing Institute of Genomics, CAS Key Laboratory of Genomic and Precision Medicine, Chinese Academy of Sciences / China National Centre for Bioinformation, Beijing, China.
  • University of Chinese Academy of Sciences, Beijing, China.

ORCID-Profile: Monika Moir, Anup Mazumder, Alessandra Pavan Lamarca, Houriiyah Tegally, James Emmanuel San, Ana Tereza R Vasconcelos, Joicymara S Xavier

Förderung

  • NIAID NIH HHS
  • FIC NIH HHS
  • Department of Science and Innovation, South Africa
  • South African Medical Research Council
  • National Institute of Health USA
  • INFORM Africa
  • Rockefeller Foundation
  • H3BioNet Africa

Zitieren

APA

van Wyk, S., Moir, M., Banerjee, A., Bazykin, G. A., Biswas, N. K., Sitharam, N., Das, S., Ma, W., Maitra, A., Mazumder, A., Karim, W. A., Lamarca, A. P., Li, M., Nabieva, E., Tegally, H., San, J. E., Vasconcelos, A. T. R., Xavier, J. S., Wilkinson, E., & de Oliveira, T. (2024). “The COVID-19 pandemic in BRICS: Milestones, interventions, and molecular epidemiology”. PLOS Global Public Health, 4(12), e0003023. https://doi.org/10.1371/journal.pgph.0003023

Vancouver

van Wyk S, Moir M, Banerjee A, Bazykin GA, Biswas NK, Sitharam N, et al. “The COVID-19 pandemic in BRICS: Milestones, interventions, and molecular epidemiology”. PLOS Global Public Health. 2024;4(12):e0003023. doi:10.1371/journal.pgph.0003023

BibTeX
@article{vanWyk2024,
  author = {van Wyk, Stephanie and Moir, Monika and Banerjee, Anindita and Bazykin, Georgii A and Biswas, Nidhan K and Sitharam, Nikita and Das, Saumitra and Ma, Wentai and Maitra, Arindam and Mazumder, Anup and Karim, Wasim Abdool and Lamarca, Alessandra Pavan and Li, Mingkun and Nabieva, Elena and Tegally, Houriiyah and San, James Emmanuel and Vasconcelos, Ana Tereza R and Xavier, Joicymara S and Wilkinson, Eduan and de Oliveira, Tulio},
  title = {“The COVID-19 pandemic in BRICS: Milestones, interventions, and molecular epidemiology”},
  journal = {PLOS Global Public Health},
  year = {2024},
  volume = {4},
  number = {12},
  pages = {e0003023},
  doi = {10.1371/journal.pgph.0003023}
}
Kostenlos starten →